Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
68,021.28 +375.02 (+0.55%) CMC Crypto 200
1,427.57 -1.00 (-0.07%)
CORT Jun 2024 23.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:24AM EDT. Market open.
| Previous close | 0.2300 |
| Open | 0.3500 |
| Bid | 0.2500 |
| Ask | 3.7000 |
| Strike | 23.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.3400 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 876 |
ZacksCorcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?
Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GuruFocus.comInsider Sale: Chief Development Officer William Guyer Sells 30,000 Shares of Corcept ...
On May 28, 2024, William Guyer, the Chief Development Officer of Corcept Therapeutics Inc (NASDAQ:CORT), executed a sale of 30,000 shares of the company.
ZacksCorcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
Corcept's (CORT) phase III GRACE study, evaluating its lead candidate, relacorilant, for treating patients with Cushing's syndrome, meets the primary endpoint in a randomized withdrawal phase.
© 2024 Yahoo. All rights reserved.